We employed CRISPR-Cas9 gene editing, delivered via lipid nanoparticles (LNPs), to selectively knock out Casp1 and Casp11 (murine homolog of human CASP5) in keratinocytes within the IMQ-induced psoriasis mouse model. Here, CASP1 is linked to psoriasis.